/CME

CME Stock - CME Group Inc.

Q: What is the analyst price target for CME?

Analyst price target information is not currently available for CME.

Q: What is CME's market cap?

Market capitalization information is not currently available for CME.

Financial Services|Financial - Data & Stock Exchanges|NASDAQ

$268.45+1.31%

+$3.47 (+1.31%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+13.1%upside

Target: $303.62

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CME

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.29

52W High$290.79

52W Low$225.47

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$6.13B	$5.58B	$5.02B	$4.69B	$4.88B
Gross Profit	$5.28B	$4.75B	$4.27B	$3.85B	$4.03B
Gross Margin	86.1%	85.1%	85.0%	82.2%	82.5%
Operating Income	$3.93B	$3.44B	$3.02B	$2.65B	$2.64B
Net Income	$3.53B	$3.23B	$2.69B	$2.64B	$2.11B
Net Margin	57.5%	57.8%	53.6%	56.2%	43.1%
EPS	$9.69	$8.87	$7.41	$7.30	$5.88

Company Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Visit Website

Earnings History & Surprises

CME

Beat Rate

94%

Last 18 quarters

Avg Surprise

+2.2%

EPS vs Estimate

Beats / Misses

17/0

1 met exactly

Latest EPS

$2.68

Q4 2025

EPS Surprise History

Q1 24

+3.9%

$2.37vs$2.28

Q2 24

+2.0%

$2.50vs$2.45

Q3 24

+1.2%

$2.56vs$2.53

Q4 24

+0.8%

$2.68vs$2.66

Q1 25

+2.4%

$2.52vs$2.46

Q2 25

0.0%

$2.80vs$2.80

Q3 25

+1.7%

$2.96vs$2.91

Q4 25

+1.9%

$2.68vs$2.63

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 21, 2026	—	—	—	—
Q1 2026	Feb 4, 2026	$2.72	—	—	—
Q4 2025	Oct 22, 2025	$2.63	$2.68	+1.9%	✓ BEAT
Q3 2025	Jul 23, 2025	$2.91	$2.96	+1.7%	✓ BEAT
Q2 2025	Apr 23, 2025	$2.80	$2.80	0.0%	= MET
Q1 2025	Feb 12, 2025	$2.46	$2.52	+2.4%	✓ BEAT
Q4 2024	Oct 23, 2024	$2.66	$2.68	+0.8%	✓ BEAT
Q3 2024	Jul 24, 2024	$2.53	$2.56	+1.2%	✓ BEAT
Q2 2024	Apr 24, 2024	$2.45	$2.50	+2.0%	✓ BEAT
Q1 2024	Feb 14, 2024	$2.28	$2.37	+3.9%	✓ BEAT
Q4 2023	Oct 25, 2023	$2.22	$2.25	+1.4%	✓ BEAT
Q3 2023	Jul 26, 2023	$2.20	$2.30	+4.5%	✓ BEAT
Q2 2023	Apr 26, 2023	$2.38	$2.42	+1.7%	✓ BEAT
Q1 2023	Feb 8, 2023	$1.88	$1.92	+2.1%	✓ BEAT
Q4 2022	Oct 26, 2022	$1.94	$1.98	+2.1%	✓ BEAT
Q3 2022	Jul 27, 2022	$1.93	$1.97	+2.1%	✓ BEAT
Q2 2022	Apr 27, 2022	$2.00	$2.11	+5.5%	✓ BEAT
Q1 2022	Feb 9, 2022	$1.64	$1.66	+1.2%	✓ BEAT
Q4 2021	Oct 27, 2021	$1.55	$1.60	+3.2%	✓ BEAT
Q3 2021	Jul 28, 2021	$1.61	$1.64	+1.9%	✓ BEAT

Frequently Asked Questions about CME

What is CME's current stock price?

CME Group Inc. (CME) is currently trading at $268.45 per share. The stock has moved +1.31% today.

What is the analyst price target for CME?

The average analyst price target for CME is $303.60, based on 1 analyst.

What sector is CME Group Inc. in?

CME Group Inc. operates in the Financial Services sector, specifically within the Financial - Data & Stock Exchanges industry. The company is traded on the NASDAQ exchange.

What is CME's market cap?

CME Group Inc. has a market capitalization of $96.80 billion, making it a large-cap company.

Does CME pay dividends?

No, CME Group Inc. does not currently pay a dividend to shareholders.